Abstract:Abstract Background It was demonstrated that multifunctional protein APE1 (Apurinic/apyrimidinic endonuclease 1) is closely related to tumor immune microenvironment in a number of investigations, Meanwhile, the abundance of tumor infiltrating lymphocytes (TILs) has been shown as a prognosis indicator in some researches. However, it remains unclear whether APE1 is involved in the process of TILs affecting the prognosis of patients. To this end, we investigated the associations between APE1 and TILs in non-small cell lung cancer (NSCLC) and explored whether APE1 would influence the associations of CD4 + T cells infiltration with the prognosis of patients. Methods Genome-wide expression datasets were obtained from the Gene Expression Omnibus (GEO) public database under accession number GSE68465, GSE30219, GSE31210 and GSE50081. MCPcounter and CIBERSORT analysis was conducted to evaluate the abundance of TILs in 1006 NSCLC patients of GEO database. Spearman correlation tests were used to evaluate correlations between abundance of various TILs and APE1 expression. RFS (recurrence free survival) was estimated using the Kaplan–Meier method and the Cox proportional-hazards model. The expression level of APE1 and tumor-infiltrating CD4 + T cells was evaluated by immunohistochemistry (IHC). Results The results showed that the abundance of CD4 + naïve T cells was negatively associated with the APE1 expression. CD4 + naïve T cells infiltration was a favorable prognostic factor for RFS, however, there was no effect of CD4 + T cells infiltration on RFS in patients with high APE1 expression. Subsequently, it was further confirmed that CD4 + T cells infiltration was negatively associated with the APE1 expression level in 108 NSCLC tissue samples; high CD4 + T cells infiltration was associated with longer RFS in low APE1 expression group but not in APE1 high expression group. Conclusion These results suggested that APE1 may affect the relationship between CD4 + T cells infiltration and prognosis in NSCLC. This study provides new insights into predictors of outcome in patients with NSCLC, and suggests that combining immunotherapy and APE1-targeted therapy may be a promising treatment for NSCLC.

[Silencing Effect of APE1 on the Radiosensitivity of Non-small Cell Lung Cancer Cells].

Anti-proliferation and Chemo-Sensitization Effects of Apigenin on Human Lung Cancer Cells

Silencing of Heat Shock Protein 27 Increases the Radiosensitivity of Non‑small Cell Lung Carcinoma Cells.

Downregulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 enhances the sensitivity of human pancreatic cancer cells to radiotherapy in vitro.

APE1 Overexpression Promotes the Progression of Ovarian Cancer and Serves As a Potential Therapeutic Target

Influences of APE1 Gene Silence on Biological Behavior of Human Hepatoma Carcinoma Cell Line MHCC97-H

Small-molecule Inhibition of APE1 Induces Apoptosis, Pyroptosis, and Necroptosis in Non-Small Cell Lung Cancer

Effect of HIF-1αby RNAi on Radiosensitivity in Esophageal Squamous Carcinoma Cell Line Eca109 under Hypoxia

Effect of Neuropilin-1 on Radio-Sensitivity of Non-Small Cell Lung Carcinoma

Small Interfering Rna Against The Apurinic Or Apyrimidinic Endonuclease Enhances The Sensitivity Of Human Pancreatic Cancer Cells To Gemcitabine In Vitro

GADD45α Sensitizes Cervical Cancer Cells to Radiotherapy Via Increasing Cytoplasmic APE1 Level

SiRNA directing at the apurineic/aprimidinic endonuclease enhances the sensitivity of human pancreatic cancer cells to gemcitabine in vitro: siRNA against APE1 of pancreatic cancer

Effect of HIF-1α Siliencing on Human Lung Cancer Xenografts Radiosensitivity in Nude Mice

APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC

[Effect of XPA Expression on the Chemotherapy Sensitivity of A549/DDP Cells].

Inhibitors of APE1 redox and ATM synergistically sensitize osteosarcoma cells to ionizing radiation by inducing ferroptosis

Analysis of Radiosensitivity of A549 Lung Cancer Cells with HIF-1α Silencing by RNAi

Effect of Ionizing Radiation on Apoptosis of Lung Cancer H460 Cells and Its Mechansim

Prediction of Survival Prognosis of Non-Small Cell Lung Cancer by APE1 Through Regulation of Epithelial-Mesenchymal Transition

Inhibiting GLUT-1 expression and PI3K/Akt signaling using apigenin improves the radiosensitivity of laryngeal carcinoma in vivo

Role of the NRP-1-mediated VEGFR2-independent pathway on radiation sensitivity of non-small cell lung cancer cells